Abstract
Introduction Magnetic resonance imaging (MRI) is a widely used diagnostic tool, but its safety during pregnancy remains a topic of concern. This study aimed to assess the current practices and attitudes towards MRI safety during pregnancy in Egypt.
Methods A survey was conducted among 41 MRI facilities across the country, with a response rate of 85%. The survey assessed patient load, safety protocols, screening procedures, administration of contrast agents, follow-up assessments, and consent requirements for MRI during pregnancy.
Results The majority of facilities (45%) reported a patient load between 100 and 200 exams per month. Regarding safety protocols, only 28% of facilities had a written policy on the exposure of pregnant patients to magnetic fields, while a mere 12% had a written policy on the exposure of pregnant health workers to MRI. Although 86% of facilities had a special MRI screening form, 27% did not consistently inquire about pregnancy during the screening procedure. Only 32% of facilities administered MRI contrast agents to pregnant patients when necessary. None of the facilities conducted regular follow-up assessments for babies exposed to the magnetic field in utero. Approximately 62% of facilities required special consent for MRI during pregnancy, with the patient herself (38%) and the husband (28%) being the common signatories.
Conclusion The study highlights the need for enhanced awareness and implementation of MRI safety guidelines during pregnancy in Egyptian healthcare facilities. Standardized protocols, improved screening procedures, regular follow-up assessments, and informed consent are crucial to ensure the safety and well-being of pregnant patients and healthcare workers. These findings provide a basis for future research and policy development to optimize MRI safety practices in Egypt.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involving human subjects was conducted in accordance with ethical guidelines and received approval from the Research Ethics Committee, Faculty of Medicine, Zagazig University. The approval number for this study is 315164316. All participants provided informed consent or consent was waived, as per the approved protocol. Prior to the commencement of the study, the Research Ethics Committee, Faculty of Medicine, Zagazig University, granted approval (IRB000455536) for the research to be conducted. Additionally, the study obtained approval from the board at each participating institute.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.